EVELYN ARIGBE: Open Payments
NPI 1639627953 · HOLMDEL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$556 in 33 payments from 15 companies in 2025. Trend: 2023 $53 · 2024 $518 · 2025 $556
Food & beverage: $556
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $113 |
| E.R. Squibb & Sons, L.L.C. | 6 | $105 |
| Celgene Corporation | 3 | $50 |
| Azurity Pharmaceuticals, Inc. | 3 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
| Agios Pharmaceuticals, Inc. | 2 | $32 |
| Merck Sharp & Dohme LLC | 2 | $32 |
| Aveo Pharmaceuticals, Inc. | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: OPDIVO, REBLOZYL, DANZITEN, ERLEADA, TECVAYLI, PYRUKYND, FOTIVDA, OJJAARA.
Industry payments across NJ — which companies pay providers there.
